Thorne Healthtech

Thorne Healthtech Equity

Delisted

The The Equity of Thorne Healthtech (THRN) as of Nov 3, 2026 is 144.99 M USD. In the previous year, The Equity was 118.53 M USD — a change of 22.32% (higher).

Equity

144.99 MUSD

YoY

22.32%

Last updated:

In 2022, Thorne Healthtech's equity was 144.99 M USD, a 22.32% increase from the 118.53 M USD equity in the previous year.

The Thorne Healthtech Equity history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Equity
Date
Equity
Jan 1, 2019
-101.07 M USD
Jan 1, 2020
-80.39 M USD
Jan 1, 2021
118.53 M USD
Jan 1, 2022
144.99 M USD
The Thorne Healthtech Equity history
YEAREquityYoY
144.99 MUSD+22.32%
118.53 MUSD-247.45%
-80.39 MUSD-20.46%
-101.07 MUSD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Thorne Healthtech Stock analysis

What does Thorne Healthtech do? Thorne Healthtech Inc is a leading company in the health and wellness industry based in the USA. Founded in 1984 by Al Czap, a former Olympic champion and naturopath, Thorne Healthtech Inc has focused on producing high-quality dietary supplements. The history of Thorne Healthtech Inc began with the goal of improving people's health and well-being. The founder, Czap, believed that it was necessary to strengthen the body from the inside out to achieve long-term health. He started integrating naturopathic principles into his work and developing natural-based dietary supplements. Thorne Healthtech Inc's business model is based on the development and production of high-quality dietary supplements tailored to the needs of customers. The company has a strong research and development department that constantly develops new innovative products and improves existing ones. Thorne Healthtech Inc adheres to strict quality standards in manufacturing, and the products are produced under the supervision of experts. The company has divided itself into different divisions to offer customers a wide range of health products. One of the divisions is Performance Products, specifically tailored to athletes. This can include dietary supplements for post-workout recovery, collagen for joint health support, or supplements to enhance endurance and strength. Another division is Immune System Products. Here, Thorne Healthtech Inc offers a variety of dietary supplements designed to strengthen the immune system and protect the body against diseases and infections. This includes vitamins, herbs, minerals, and probiotic supplements. Another important area is Nutrient Supplements. Thorne Healthtech Inc produces a wide range of dietary supplements that can help provide the body with the necessary amount of nutrients. These include folic acid, magnesium, vitamin B12, and vitamin C. A particularly important area for the health industry is the Laboratory Tests sector. Thorne Healthtech Inc offers various tests for interested customers to better understand their health condition. These include tests for vitamins, minerals, probiotics, allergies, and more. In conclusion, Thorne Healthtech Inc is a company specialized in improving the physical and mental health of people through the production of high-quality dietary supplements. The company has a long history and extensive experience in naturopathy, and follows strict quality standards in product manufacturing. With a wide range of health and wellness products and excellent customer service, Thorne Healthtech Inc aims to support its customers in leading healthier lives. Thorne Healthtech is one of the most popular companies on Eulerpool.

Equity Details

Analyzing Thorne Healthtech's Equity

Thorne Healthtech's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Thorne Healthtech's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Thorne Healthtech's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Thorne Healthtech's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Thorne Healthtech’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Thorne Healthtech stock

The Equity of Thorne Healthtech is 144.99 M USD in 2022.

The Equity of Thorne Healthtech changed from 118.53 M USD to 144.99 M USD, representing a 22.32% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of The Equity Thorne Healthtech since 2006 – with annual values, charts, and detailed analysis.

The Equity's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track The Equity's Thorne Healthtech historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Thorne Healthtech

All Key Metrics — Thorne Healthtech